Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.95
Rein Therapeutics, Inc.: Amended certificate of incorporation to change company name from Aileron Therapeutics, Inc. to Rein Therapeutics, Inc (effective 2025-01-10).
- Change
- charter amendment
- Effective
- 2025-01-10
Exact text from the filing
On January 10, 2025, Aileron Therapeutics, Inc. (the “Company”) amended its Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to effect a change of the Company’s name from “Aileron Therapeutics, Inc.” to “Rein Therapeutics, Inc.” (the “Name Change”). The Name Change became effective at 4:00 p.m. Eastern Time on January 10, 2025.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.95
Rein Therapeutics, Inc.: Amended and restated bylaws solely to reflect company name change from Aileron Therapeutics, Inc. to Rein Therapeutics, Inc (effective 2025-01-10).
- Change
- bylaw amendment
- Effective
- 2025-01-10
Exact text from the filing
In connection with the Name Change, the Board also approved an amendment and restatement of the Company’s Amended and Restated Bylaws solely to reflect the Name Change (as amended and restated, the “Amended and Restated Bylaws”) effective as of January 10, 2025.
View on SEC.gov